In summary, taurine has a minimal influence on insulin sensitization in individuals with minor metabolic disorders (such as being overweight), but exerts a more pronounced effect in those with severe insulin resistance (such as obesity or diabetes). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.